Global Autoinjector Contract Manufacturing Market

Report ID : 1340 | Published : 2022-07-21 | Pages: 197 | Format: PDF/EXCEL

The market size of the global Autoinjector Contract Manufacturing Market in the year 2021 is valued at 1.16 billion and is predicted to reach 2.80 billion by the year 2030 at an 10.4% CAGR during the projected period.

Autoinjectors are self-injecting devices. They are a significant type of medical device that may administer medications subcutaneously or intramuscularly. They contain spring-driven prefilled syringes or cartridges. As medical equipment, autoinjectors primarily dispense drugs. They are typically utilized by healthcare experts due to their various advantages. An autoinjector is preferable to alternative methods because it maintains medicine dosage precision and lessens needle anxiety, among other benefits. The market for Autoinjector Contract Manufacturing is expanding as a result of rising anaphylaxis, targeted treatments, and regulatory approvals. The prevalence of disorders including diabetes, rheumatoid arthritis, multiple sclerosis, and others is increasing, which is what is driving the global market for auto-injectors. Age is a factor in rheumatoid arthritis risk, which peaks between the ages of 35 and 50. Therefore, it is projected that an increase in the elderly population will fuel the global market for autoinjector contract manufacturing. The global market is anticipated to be driven by an increase in the number of injectable medications. In addition, the use of new technologies is a significant driver that is projected to boost the global market for autoinjector contract manufacturing. The ease of use, lower risk of infection, and mobility of auto-injectors have increased their use, which in turn has boosted the growth of the global market for these devices. The infrastructure for health care is being modernized by governments in emerging nations, which is expected to expand access to healthcare. This is anticipated to increase demand for cutting-edge technology, which would in turn provide attractive market prospects for autoinjector contract manufacturing around the world.

 

 

The growing popularity of alternate drug delivery techniques like nasal and oral medication delivery limits the market for Autoinjector Contract Manufacturing. Autoinjectors can reduce needle-related anxiety to some extent, but they cannot completely eliminate it. This is especially true for children and young people, which also acts as a barrier to the market's expansion for Autoinjector Contract Manufacturing.

Market Segmentation:

The Autoinjector Contract Manufacturing Market is segmented on the basis of Product, Application, and End-User. Based on Product, the market is segmented as Disposable Autoinjectors, Reusable Autoinjectors, Wearable Injector, Smart/Connected Autoinjectors. Based on Application, the market is segmented as Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, and Others. Based on End-User, the market is segmented as Homecare, Hospitals & Clinics, and Ambulatory Services.

Based on application, the rheumatoid arthritis segment is accounted as a major contributor to the Autoinjector Contract Manufacturing Market

The market for rheumatoid arthritis autoinjectors accounted for the majority of sales. Autoinjectors enable patients with rheumatoid arthritis to self-administer their medications because they are frequently unable to inject their medications. The rheumatoid arthritis sector is anticipated to maintain its commanding market position given the rising geriatric population and the increasing number of rheumatoid arthritis cases over the world. The primary drivers driving the growth of the segment are the entry of biosimilar drugs, a rise in the elderly population, an increase in the use of conventional DMARDs, and government initiatives to disseminate awareness of rheumatoid arthritis symptoms. Other reasons that contribute to the segment expansion include advancements in advanced biologics, an increase in healthcare spending, increased purchasing power, and access to high-quality medications for poor and middle-class families worldwide.

Based on End-User, the home care segment is accounted as a major contributor to the Autoinjector Contract Manufacturing Market

The market for Autoinjector Contract Manufacturing was dominated by the home care segment. Autoinjector Contract Manufacturing eliminate the need for specialized medical care when giving medication to elderly individuals who frequently need periodic injections of their medications. Additionally enabling patients to self-administer medication and lowering the cost per injection are Autoinjector Contract Manufacturing. The two main factors driving the homecare market are the aging population and the demand for less expensive treatments. The market for home care services is being supported by the existence of numerous organizations providing these services in North America and Europe. The category is therefore predicted to grow during the forecast period due to an increase in the elderly population and nursing home care.

In the region, the North America Autoinjector Contract Manufacturing Market holds a significant revenue share.

North America is expected to have a significant market share for autoinjector contract manufacturing over the projection period due to the early acceptance of technologically sophisticated goods and product approvals. The high diabetes population and rising healthcare infrastructure, which have attracted several prominent autoinjector device manufacturers to this region, are the main drivers of market growth in the region. Through various strategies, including opening sales offices and collaborating with regional pharmaceutical firms, these businesses are expanding their footprint in the regional market. The rise in incidences of anaphylaxis, rheumatoid arthritis, and other illnesses like anemia and migraine, as well as continued corporate technical developments, are predicted to boost the market's overall expansion.

Competitive Landscape

Some of the major key players in the Autoinjector Contract Manufacturing Market are Phillips-Medisize (a Molex Company), Elcam Drug Delivery Devices (E3D) (Elcam Medical), Jabil Healthcare, Dali Medical Devices, Ypsomed Delivery Systems (YDS), SHL Medical, Haselmeier, Owen Mumford, Becton, Dickinson and Company (BD), CCBio, Nemera (Copernicus), Recipharm AB, Sonceboz, Solteam Medical, Stevanato Group, Union Medico ApS., Neuma Engineering, Emperra, Eitan Medical, Enable Injections, West Pharmaceutical Services, Inc., Delfu Medical, Wanhai Medical, and Other Prominent Player.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Autoinjector Contract Manufacturing Market Snapshot

Chapter 4. Global Autoinjector Contract Manufacturing Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis

5.1. By Product & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Product:

5.2.1. Disposable Autoinjectors

5.2.2. Reusable Autoinjectors

5.2.3. Wearable Injector

5.2.4. Smart/Connected Autoinjectors

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis

6.1. By Application & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Application:

6.2.1. Anaphylaxis

6.2.2. Rheumatoid Arthritis

6.2.3. Multiple Sclerosis

6.2.4. Diabetes

6.2.5. Others

Chapter 7. Market Segmentation 3: By End-user Estimates & Trend Analysis

7.1. By End-user & Market Share, 2020 & 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-user:

7.2.1. Homecare

7.2.2. Hospitals & Clinics

7.2.3. Ambulatory Services

Chapter 8. Autoinjector Contract Manufacturing Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Product, 2020-2030

8.1.2. North America Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2020-2030

8.1.3. North America Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2020-2030

8.1.4. North America Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2030

8.2. Europe

8.2.1. Europe Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) By Product, 2020-2030

8.2.2. Europe Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2020-2030

8.2.3. Europe Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2020-2030

8.2.4. Europe Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) By Product, 2020-2030

8.3.2. Asia Pacific Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2020-2030

8.3.3. Asia Pacific Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2020-2030

8.3.4. Asia Pacific Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.4. Latin America

8.4.1. Latin America Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) By Product, 2020-2030

8.4.2. Latin America Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2020-2030

8.4.3. Latin America Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2020-2030

8.4.4. Latin America Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) By Product, 2020-2030

8.5.2. Middle East & Africa Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2020-2030

8.5.3. Middle East & Africa Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2020-2030

8.5.4. Middle East & Africa Autoinjector Contract Manufacturing Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

 9.2.1. Phillips-Medisize (a Molex Company)

9.2.2. Elcam Drug Delivery Devices (E3D) (Elcam Medical)

9.2.3. Jabil Healthcare

9.2.4. Gerresheimer AG

9.2.5. Dali Medical Devices

9.2.6. Ypsomed Delivery Systems (YDS)

9.2.7. SHL Medical

9.2.8. Haselmeier

9.2.9. Owen Mumford

9.2.10. Becton, Dickinson and Company (BD)

9.2.11. CCBio

9.2.12. Nemera (Copernicus)

9.2.13. Recipharm AB

9.2.14. Sonceboz

9.2.15. Solteam Medical

9.2.16. Stevanato Group

9.2.17. Union Medico ApS.

9.2.18. Neuma Engineering

9.2.19. Emperra

9.2.20. Eitan Medical

9.2.21. Enable Injections

9.2.22. West Pharmaceutical Services, Inc.

9.2.23. Delfu Medical

9.2.24. Wanhai Medical

9.2.25. Other Prominent Player

Segmentation of Autoinjector Contract Manufacturing Market-

By Product

  • Disposable Autoinjectors
  • Reusable Autoinjectors
  • Wearable Injector
  • Smart/Connected Autoinjectors

 

 

By Application

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Others

By End-User

  • Homecare
  • Hospitals & Clinics
  • Ambulatory Services

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Global Autoinjector Contract Manufacturing Market?

Autoinjector Contract Manufacturing Market worth US$ 2.80 Billion by 2030

CAGR of 10.4% during the forecast period of 2022-2030

Our Clients